“We’ve Been Here Before”: Cannabis Industry Reacts to 2026 Midterm Election Results

Burn After Reading The 30-second intel for operators and investors ⏱ 0:30

Democrats win both chambers of Congress, and Massachusetts voters reject Question 8, which would have ended adult-use sales and threatened a market of about $1.6 billion a year. Industry leaders stay cautious on federal reform.

• Operators: Massachusetts operators lose the threat of a voter-mandated adult-use shutdown. Nationally, capital stays scarce and expensive, and the election does not change financing, banking access or federal protections on its own.
• Investors: The results add potential upside for banking reform but do not alter balance sheets or financing. The House passed SAFE Banking seven times, yet it never received a Senate floor vote. Rescheduling runs on a separate track.
• Do now: Review your financing and compliance plans to confirm they do not assume federal banking reform or broader rescheduling arrives soon, and track Senate committee leadership changes.

Short on time? You’re done. Want the numbers?Keep reading ↓

Democrats’ congressional victories and the defeat of cannabis restrictions in Massachusetts and Idaho have industry leaders cautiously optimistic. But executives and advocates warn that electoral success does not guarantee federal reform.

The 2026 U.S. midterm elections have reshaped the political landscape for the cannabis industry, with Democrats winning control of both chambers of Congress and voters in Massachusetts and Idaho rejecting measures that could have restricted legal cannabis markets or future legalization efforts.

The results have prompted reactions from cannabis executives, industry advocates and policy organizations, who see new opportunities for federal banking reform, improved access to capital and greater protection for state-regulated markets.

Yet the responses received by IgniteIt share an important qualification: a more favorable political environment does not necessarily translate into legislation.

For investors and operators, the distinction matters. Federal cannabis banking legislation has attracted bipartisan support for years without becoming law, while businesses continue to navigate high financing costs, regulatory uncertainty and uneven access to federal protections.

NewLake CEO: Congressional Control Creates Opportunity, Not Certainty

Anthony Coniglio, CEO of NewLake Capital Partners (OTCQX: NLCP), sees the Democratic victories as a potential turning point for cannabis policy, particularly in the Senate.

“Tuesday’s historic election results put Democrats squarely in the driver’s seat in Congress for the next two years, with control of both the House and the Senate,” Coniglio said in a statement procured by IgniteIt.

“For the cannabis industry, that could create an opportunity to move banking reform and other legislation forward, but we’ve been here before.”

Coniglio pointed to the industry’s long history of legislative disappointments.

“Cannabis banking reform has had bipartisan support for years, yet under majorities of both parties, Congress has been unable to get it done. The House passed the SAFE Banking Act seven times, and the Senate Banking Committee approved it in 2023, but it has never received a vote on the Senate floor.”

His assessment highlights the difference between political support and the ability to move legislation through Congress.

“A change in leadership doesn’t by itself change that record,” he added.

The incoming Senate could nevertheless offer a different legislative environment.

“What is different is the makeup of the incoming Senate. Key committee gavels are expected to move to members who have supported cannabis reform, and the new Senate should include more senators who support reform than the outgoing class. That improves the odds, but it doesn’t guarantee an outcome.”

For cannabis businesses, banking reform would address a longstanding obstacle to conventional financing and financial services.

Coniglio connected that issue to the industry’s broader operating conditions.

“Capital remains scarce and expensive, and that’s a challenge for operators across the industry.”

He also emphasized the importance of regulated access for consumers and patients, arguing that reforms should help state-legal businesses compete with unregulated alternatives.

Federal Rescheduling Remains a Separate Process

Despite the change in congressional control, Coniglio cautioned against interpreting the election as a direct catalyst for federal cannabis rescheduling.

“State-licensed medical cannabis has already moved to Schedule III, and we remain confident the broader rescheduling proceeding will reach the same result. The timing is uncertain, and that process will continue independently of the election results.”

The distinction is significant for cannabis investors.

The federal government has established a Schedule III pathway for certain qualifying medical cannabis activities, but broader federal reform remains unresolved. The new Congress could influence cannabis legislation, while administrative rescheduling continues through a separate process.

Coniglio said NewLake would not base its investment strategy on expectations about Washington.

“We are not making investment decisions based on what we think Washington might do. We remain focused on the underlying real estate, the strength of our tenants, and the cash flow those properties generate.”

He added that federal reform could still improve the operating environment for cannabis businesses and, consequently, NewLake’s portfolio.

Massachusetts Vote Protects an Established Cannabis Market

The national political shift coincided with a decisive victory for the regulated cannabis industry in Massachusetts.

Voters rejected Question 8, which would have ended licensed adult-use cannabis sales beginning January 1, 2028.

With roughly three-quarters of voters opposing the measure in preliminary results, the outcome preserved a market generating approximately $1.6 billion in annual adult-use sales.

The result also removed a significant potential threat to existing dispensaries, cultivation businesses, employees and state tax revenue.

David Bodurtha, Massachusetts Commercial General Manager for RISE Dispensaries, described the outcome as an endorsement of the state’s regulated marketplace.

“Massachusetts voters have reaffirmed what 10 years of a functioning legal market have demonstrated: regulated cannabis delivers real benefits for the Commonwealth,” Bodurtha told IgniteIt.

“Rejecting Question 8 ensures patients and adult-use customers can continue accessing tested products through licensed dispensaries, preserves jobs, supports local businesses, and protects critical tax revenue.”

For existing operators, the vote eliminates the immediate possibility of a voter-mandated shutdown of adult-use retail sales.

But it also carries a broader implication: voters were asked to reconsider a legalization decision made a decade earlier and overwhelmingly chose to preserve the regulated system.

“This outcome underscores that dismantling an established industry would have taken Massachusetts backward, putting the benefits of legal adult-use cannabis at risk without eliminating cannabis demand,” Bodurtha said.

“We remain focused on serving our patients and customers while supporting Massachusetts’ continued economic growth.”

Marijuana Policy Project: Massachusetts Voters Defend Legalization

Adam J. Smith, executive director of the Marijuana Policy Project (MPP), characterized the Massachusetts result as a rejection of efforts to reverse legalization.

“Despite a well-funded scare campaign, Massachusetts voters have chosen common sense by defeating the ballot initiative to end the state’s legal adult-use cannabis market,” Smith said in a statement obtained by IgniteIt.

Smith argued that the vote reflected public recognition of the benefits of regulated cannabis, including consumer protections, employment, tax revenue and reductions in cannabis-related arrests.

MPP noted that Massachusetts voters originally approved adult-use legalization in 2016 with 53.6% support.

The organization estimates that the state’s cannabis industry now supports approximately 23,000 jobs and generates nearly $300 million annually in state and local tax revenue.

Idaho Voters Preserve a Pathway for Future Cannabis Reform

A separate election result in Idaho could have implications for future cannabis legalization campaigns.

Voters rejected House Joint Resolution 4, a proposed constitutional amendment that would have reserved authority over legalizing marijuana and certain other substances exclusively for the state legislature.

Its defeat preserves the possibility of pursuing cannabis reform through citizen-led ballot initiatives.

Smith described the result as a significant victory for grassroots advocacy.

“Idaho voters have scored a major victory for citizen-led advocacy and common sense by soundly rejecting HJR 4,” he said in a separate statement obtained by IgniteIt.

The MPP executive director criticized Idaho’s existing cannabis penalties and argued that the proposal would have restricted citizens’ ability to advance drug policy changes independently of lawmakers.

“We applaud Idaho’s voters for sending this powerful message to their elected representatives,” Smith said.

Unlike Massachusetts, Idaho has not established a regulated adult-use cannabis marketplace. The vote therefore does not immediately create new commercial opportunities or authorize cannabis sales.

Its significance is procedural and political: advocates retain a potential route to pursue legalization through future elections.

For the cannabis industry, the Massachusetts and Idaho outcomes represent different stages of the same policy debate. One state protected an existing commercial market; the other preserved a mechanism that could eventually allow voters to establish one.

Project Champion: The Industry Cannot Rely on a Democratic Congress Alone

Gretchen Gailey, president of Project Champion and founder of Panoptic Strategies, offered a broader interpretation of the election results.

In an op-ed piece provided to IgniteIt following the Massachusetts vote, Gailey argued that the industry’s success depended on cooperation among businesses, advocates, and voters rather than political party affiliation.

“Massachusetts voters sent an unmistakable message on Election Day: they are not interested in going backward,” she wrote.

Gailey credited the Stop the Repeal campaign and its supporters, including former NFL running back Ricky Williams, who participated in voter outreach efforts.

Project Champion supported the campaign despite having no direct commercial interests in Massachusetts.

“An attack on one part of this industry is an attack on all of us,” Gailey wrote.

Her argument extends beyond the Massachusetts referendum to the industry’s approach to federal policymaking.

“Nor should anyone assume that the so-called blue wave in Congress guarantees a friendlier environment for cannabis reform,” she wrote.

“We have been here before. When Democrats controlled both chambers of Congress, the industry still failed to secure meaningful federal legislative progress on priorities such as SAFE Banking and comprehensive cannabis reform.”

Gailey also raised concerns about the limited scope of federal Schedule III registrations, including questions about which businesses qualify and whether the framework could create unequal opportunities across the industry.

“A limited federal pathway for certain medical cannabis activities is not comprehensive reform. It is not descheduling,” she wrote.

Her conclusion echoed Coniglio’s concerns about legislative follow-through.

“Political alignment is not a substitute for political accountability.”

Gailey called for sustained advocacy, broader coalitions and greater engagement with elected officials.

What the Election Means for Cannabis Businesses and Investors

The immediate implications differ across federal and state policy.

At the federal level, Democratic control of Congress could change committee leadership, legislative priorities and the prospects for cannabis banking legislation. Whether those changes produce meaningful reform will depend on congressional negotiations, bipartisan support and the relationship between Congress and the Trump administration.

For investors, the results introduce potential opportunities but do not immediately alter company balance sheets, financing arrangements or operating performance.

That distinction is particularly important for an industry where access to capital, taxation, debt obligations and competition continue to influence profitability.

With a new Congress preparing to take office, questions surrounding cannabis banking, federal regulation and investment conditions are likely to remain central to industry discussions. Those issues will also be on the agenda at IgniteIt’s Cannabis Capital & Policy Summit in Washington, D.C., on November 18, where business leaders, investors and policymakers will examine the evolving relationship between federal policy and the cannabis economy.